MK-1602

· Allergan

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-1602, covering 2016-09-30 to 2016-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007) [Phase 2]